mk2 Biotechnologies GmbH. (6/28/22). "Press Release: mk2 Biotechnologies and Sartorius Stedim Biotech Join Forces to Develop a Biologics Production Platform".

	Organisation	Sartorius Stedim Biotech S.A. (SSB)
	Group	Sartorius (Group)
	Product	biopharmaceutical production technology
	Product 2	biopharmaceutical

mk2 Biotechnologies, a peptide and protein production specialist for large-scale applications, and Sartorius Stedim Biotech Corporate Research, a leading technology and solutions provider to the biotech/biopharma industry, are happy to announce that they are joining forces to create the next-generation, low-cost biologics production platform. Integrating an intensified approach, the platform aims to make a groundbreaking step forward to facilitate sustainable and cost-efficient, large-scale production of high-efficacy biologics. The collaboration will pave new ways to meet the rising global bio-based API demands.

Record changed: 2023-06-05

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)